no news_id given

NorwayNorway

05.04.2011

Oslo – Norwegian Algeta ASA has entered a research collaboration with Genzyme to evaluate the potential of its Thorium platform Under the terms of the agreement, Genzyme will provide access to a novel tumour-targeting antibody,...

NorwayNorway

05.04.2011

Trondheim – Norway-based APIM Therapeutics AS has received a follow-up investment from Sarsia Seed, one of its previous investors. APIM focusses on novel drug candidates that potentiate the action of current chemo­therapeutics to...

NorwayNorway

04.11.2010

Oslo – Norwegian diagnostic specialist DiaGenic ASA has raised NOK70m (EUR 8.5m) through the sale of 140 million shares at NOK0.50 per share in a private placement to new and existing investors. DnB NOR Markets acted as manager...

NorwayNorway

03.11.2010

Oslo – The Oslo Cancer Cluster and the Shanghai Institute of Materia Medica (SIMM), have signed a memorandum of understanding aimed at accelerating the development and adoption of new cancer therapies. Overall, the collaboration...

NorwayNorway

18.09.2010

Oslo/Berlin – Algeta is cashing in on its lead product Alpharadin, a targeted alpha-radiopharmaceutical in clinical trials for treating bone metastases in cancer patients. Bayer Schering Pharma has agreed to pay the Norwegian...

NorwayNorway

11.07.2010

Lysaker – Norwegian biopharmaceutical company PCI Biotech Holding ASA has strengthened the company’s equity by a11m (NOK90m) through a share issue of 2.25 million shares with preemptive subscription rights for existing...

Displaying results 11 to 20 out of 93

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/news/messages-archive/archive-norway/browse/1.html

Events

All Events

Stock list

All quotes

TOP

  • FORMYCON8.49 EUR6.79%
  • VITA 344.23 EUR4.96%
  • CO.DON2.98 EUR3.83%

FLOP

  • STRATEC BIOMEDICAL38.80 EUR-3.60%
  • MAGFORCE6.90 EUR-2.82%
  • EVONIK27.14 EUR-1.63%

TOP

  • PAION3.19 EUR31.3%
  • FORMYCON8.49 EUR24.5%
  • CO.DON2.98 EUR20.2%

FLOP

  • ADDEX3.22 CHF-19.1%
  • EVOTEC3.07 EUR-17.9%
  • 4SC1.02 EUR-16.4%

TOP

  • SANTHERA86.25 CHF2029.6%
  • PAION3.19 EUR239.4%
  • CO.DON2.98 EUR213.7%

FLOP

  • CYTOS0.21 CHF-94.6%
  • 4SC1.02 EUR-47.4%
  • MOLOGEN6.73 EUR-43.0%

No liability assumed, Date: 29.09.2014


Current issue

All issues

Product of the week

Products